Literature DB >> 17413174

Managing the menopause.

Helen Roberts1.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17413174      PMCID: PMC1847879          DOI: 10.1136/bmj.39153.522535.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  29 in total

Review 1.  Oral oestrogen replacement therapy versus placebo for hot flushes.

Authors:  A MacLennan; S Lester; V Moore
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  Guidelines for hormone treatment of women in the menopausal transition and beyond.

Authors:  F Naftolin; H P G Schneider; D W Sturdee
Journal:  Maturitas       Date:  2005-05-16       Impact factor: 4.342

Review 3.  Treatment of menopausal symptoms: what shall we do now?

Authors:  Martha Hickey; Susan R Davis; David W Sturdee
Journal:  Lancet       Date:  2005 Jul 30-Aug 5       Impact factor: 79.321

4.  Advice has changed for hormone therapy in the WHI era.

Authors:  Helen E Roberts; Cynthia M Farquhar
Journal:  Aust N Z J Obstet Gynaecol       Date:  2006-04       Impact factor: 2.100

5.  Androgen therapy in women: an Endocrine Society Clinical Practice guideline.

Authors:  Margaret E Wierman; Rosemary Basson; Susan R Davis; Sundeep Khosla; Karen K Miller; William Rosner; Nanette Santoro
Journal:  J Clin Endocrinol Metab       Date:  2006-10-03       Impact factor: 5.958

6.  Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.

Authors:  Sven O Skouby; Farook Al-Azzawi; David Barlow; Joaquin Calaf-Alsina Erdogan Ertüngealp; Anne Gompel; Alessandra Graziottin; Decebal Hudita; Amos Pines; Serge Rozenberg; Göran Samsioe; John C Stevenson
Journal:  Maturitas       Date:  2005-05-16       Impact factor: 4.342

7.  Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Authors:  Marcia L Stefanick; Garnet L Anderson; Karen L Margolis; Susan L Hendrix; Rebecca J Rodabough; Electra D Paskett; Dorothy S Lane; F Allan Hubbell; Annlouise R Assaf; Gloria E Sarto; Robert S Schenken; Shagufta Yasmeen; Lawrence Lessin; Rowan T Chlebowski
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

8.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

9.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

10.  Estrogen plus progestin and the risk of coronary heart disease.

Authors:  JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

View more
  10 in total

1.  Hormone replacement therapy comes full circle.

Authors:  Helen Roberts
Journal:  BMJ       Date:  2007-07-11

2.  Determinants of willingness to pay for a new therapy in a sample of menopausal-aged women.

Authors:  Andrej Rasch; Jan-Marc Hodek; Claus Runge; Wolfgang Greiner
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 3.  Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.

Authors:  Susan Furness; Helen Roberts; Jane Marjoribanks; Anne Lethaby
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

4.  The current state of postmenopausal hormone therapy: update for neurologists and epileptologists.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

Review 5.  Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry.

Authors:  Lisa Cosgrove; Ling Shi; David E Creasey; Maria Anaya-McKivergan; Jessica A Myers; Krista F Huybrechts
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

6.  Women's health in menopause with a focus on hypertension.

Authors:  A H E M Maas; H R Franke
Journal:  Neth Heart J       Date:  2009-02       Impact factor: 2.380

Review 7.  Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy.

Authors:  Santiago Palacios; María Jesús Cancelo
Journal:  Int J Womens Health       Date:  2016-10-26

8.  Mesenchymal Stem Cell Therapy Using Human Umbilical Cord in a Rat Model of Autoimmune-Induced Premature Ovarian Failure.

Authors:  Zhe Wang; Quanwei Wei; Hao Wang; Linxiao Han; Hongjian Dai; Xiaoxin Qian; Hongliang Yu; Manqun Yin; Fangxiong Shi; Nianmin Qi
Journal:  Stem Cells Int       Date:  2020-07-04       Impact factor: 5.443

9.  The effects of postmenopausal hormone therapy on social activity, partner relationship, and sexual life - experience from the EPHT trial.

Authors:  Elina Hemminki; Piret Veerus; Heti Pisarev; Sirpa-Liisa Hovi; Päivi Topo; Helle Karro
Journal:  BMC Womens Health       Date:  2009-06-08       Impact factor: 2.809

10.  Effects of Bushen Tianjing Recipe in a rat model of tripterygium glycoside-induced premature ovarian failure.

Authors:  Xiaofeng Xu; Yong Tan; Guorong Jiang; Xuanyi Chen; Rensheng Lai; Lurong Zhang; Guoqiang Liang
Journal:  Chin Med       Date:  2017-04-24       Impact factor: 5.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.